NCT07854704

Brief Summary

During long operations on the abdomen, patients often get cold. Doctors call this perioperative hypothermia. Even a small drop in body temperature can cause problems, such as more bleeding, wound infection, and a longer stay in hospital. To keep patients warm during surgery, doctors usually blow warm air over the body through a special blanket. However, the fluids that patients receive through a vein during surgery are normally at room temperature. These cool fluids may lower the body temperature from the inside. This study compares two ways of keeping patients warm during operations on the abdomen that last three hours or longer. Everyone taking part receives warm air blown over the body. In addition, one group receives fluids into a vein at room temperature, about 23 °C, which is the usual practice. The other group receives the same fluids warmed to 39 °C by a special device just before the fluid enters the vein. Participants are placed into one of the two groups by chance, like flipping a coin. Because of the nature of the treatment, the doctors caring for the patient know which group the patient is in. The researchers measure body temperature before, during, and at the end of surgery. They also record blood pressure, the medicines used to support blood pressure, the amount of fluid given, the amount of urine produced, and blood tests taken on the day after surgery. This is a pilot study. Its main purpose is to find out whether a larger study would be possible. The researchers want to learn how many patients can be enrolled, whether the treatment can be given exactly as planned, and how complete the collected information is. The results will be used to plan a larger study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Nov 2024Jun 2027

Study Start

First participant enrolled

November 15, 2024

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

September 25, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 2, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2027

Last Updated

October 2, 2026

Status Verified

October 1, 2026

Enrollment Period

2.4 years

First QC Date

September 25, 2026

Last Update Submit

October 1, 2026

Conditions

Keywords

perioperative hypothermiainadvertent perioperative hypothermiagoal-directed temperature managementintravenous fluid warmingforced-air warmingnormothermiaabdominal surgerypilot studyfeasibility study

Outcome Measures

Primary Outcomes (1)

  • Core body temperature at admission to the intensive care unit

    Oesophageal temperature measured at the time of transfer of the participant from the operating room to the intensive care unit, in degrees Celsius.

    At transfer to the intensive care unit, up to 12 hours after skin incision

Secondary Outcomes (14)

  • Perioperative axillary temperature

    Before induction of anaesthesia, hourly during surgery, and at admission to the intensive care unit, up to 12 hours

  • Perioperative oesophageal temperature

    Hourly from 1 hour after start of surgery until admission to the intensive care unit, up to 12 hours

  • Proportion of participants requiring norepinephrine infusion

    Intraoperative period, up to 12 hours

  • Time from skin incision to initiation of norepinephrine infusion

    Intraoperative period, up to 12 hours

  • Norepinephrine infusion rate

    Intraoperative period, up to 12 hours

  • +9 more secondary outcomes

Other Outcomes (6)

  • Proportion of screened participants who were randomised

    From start of enrolment through study completion, up to 32 months

  • Proportion of eligible participants who provided informed consent

    From start of enrolment through study completion, up to 32 months

  • Recruitment rate

    From start of enrolment through study completion, up to 32 months

  • +3 more other outcomes

Study Arms (2)

Control group

ACTIVE COMPARATOR

Forced-air warming applied through an upper body blanket at an airflow temperature of 37 °C from induction of anaesthesia until the end of surgery, combined with intravenous infusion of balanced crystalloid solutions stored at 23 °C and administered without additional warming.

Device: Forced-air warmingOther: Unwarmed intravenous fluids

Study group

EXPERIMENTAL

Forced-air warming applied through an upper body blanket at an airflow temperature of 37 °C from induction of anaesthesia until the end of surgery, combined with intravenous infusion of the same balanced crystalloid solutions actively warmed to a target temperature of 39 °C by a medical fluid warmer positioned as close as possible to the venous access site.

Device: Forced-air warmingDevice: Intravenous fluid warming

Interventions

Forced-air warming system with an upper body blanket; airflow temperature set at 37 °C; applied identically in both groups from induction of anaesthesia until the end of surgery.

Also known as: WarmTouch WT-5900
Control groupStudy group

Balanced crystalloid solutions actively warmed to a target temperature of 39 °C using a medical fluid warmer; the infusion line is placed inside the heating element as close as possible to the venous access site.

Also known as: IRIS medical fluid warmer
Study group

Balanced crystalloid solutions stored at an ambient temperature of 23 °C and administered intravenously without additional warming.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed written informed consent
  • Age 18 years or older
  • Scheduled abdominal surgery with an expected duration of at least 3 hours

You may not qualify if:

  • Pregnancy or breastfeeding
  • End-stage chronic somatic disease
  • Axillary temperature above 37.0 °C before surgery
  • Documented thermoregulatory disorder of any origin, including disorders due to ongoing infectious or autoimmune disease or traumatic brain injury
  • Chronic heart failure stage 2 according to the classification of the Russian Society of Cardiology
  • Active infection before surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Leningrad Regional Clinical Hospital

Saint Petersburg, 194291, Russia

RECRUITING

MeSH Terms

Conditions

Intraoperative ComplicationsBody Temperature Changes

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Valentin S Kozlov, MD

    The Leningrad Regional Clinical Hospital

    PRINCIPAL INVESTIGATOR
  • Ionas S Simutis, MD, Dsc

    North-Western State Medical University named after I.I.Mechnikov

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Valentin S Kozlov, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Two parallel groups; all participants receive forced-air warming, with the study group additionally receiving actively warmed intravenous fluids.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist, Department of Anesthesiology and Intensive Care

Study Record Dates

First Submitted

September 25, 2026

First Posted

October 2, 2026

Study Start

November 15, 2024

Primary Completion (Estimated)

April 15, 2027

Study Completion (Estimated)

June 15, 2027

Last Updated

October 2, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the published results will be made available to qualified researchers upon reasonable request to the corresponding author, following approval of a methodologically sound proposal.

Time Frame
Beginning 6 months after publication of the main results and ending 3 years thereafter.
Access Criteria
Requests should be directed to the corresponding author and will be evaluated on the basis of scientific merit. Data will be shared after approval of a proposal and completion of a data access agreement.

Available IPD Datasets

Study Protocol (OSF.IO/4GCFX)Access

Locations